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Single QTL Effects, Epistasis, and Pleiotropy
Account for Two-thirds of the Phenotypic F2
Variance of Growth and Obesity in DU6i x
DBA/2 Mice
Gudrun A. Brockmann,1,4,5 Ju¨rgen Kratzsch,2 Chris S. Haley,3 Ulla Renne,1
Manfred Schwerin,1 and Steffanie Karle1
1Research Institute for the Biology of Farm Animals, 18196 Dummerstorf, Germany; 2Departments of Clinical
Chemistry and Pathobiochemistry, University of Leipzig, 04103 Leipzig, Germany; 3Roslin Institute/Edinburgh,
Roslin, Midlothian EH25 9PS, United Kingdom
Genes influencing body weight and composition and serum concentrations of leptin, insulin, and insulin-like
growth factor I (IGF-I) in nonfasting animals were mapped in an intercross of the extreme high-growth mouse
line DU6i and the inbred line DBA/2. Significant loci with major effects (F > 7.07) for body weight, obesity, and
muscle weight were found on chromosomes 1, 4, 5, 7, 11, 12, 13, and 17, for leptin on chromosome 14, for insulin
on chromosome 4, and for IGF-I on chromosome 10 at the Igf1 gene locus itself and on chromosome 18.
Significant interaction between different quantitative trait loci (QTL) positions was observed (P < 0.01). Evidence
was found that loci having small direct effect on growth or obesity contribute to the obese phenotype by
gene–gene interaction. The effects of QTLs, epistasis, and pleiotropy account for 64% and 63% of the
phenotypic variance of body weight and fat accumulation and for over 32% of muscle weight and serum
concentrations of leptin, and IGF-I in the F2 population of DU6i x DBA/2 mice.
[The quantitative trait loci described in this paper have been submitted to the Mouse Genome Database.]
Growth is a complex trait that is genetically deter-
mined by gene variants controlling nutrient turnover
and energy balance. Genetic studies based on natural
pedigrees in humans and on crossbred populations in
mouse, rat, and livestock have led to the identification
of genetic components responsible for body weight,
obesity, and diabetes (for review, see Chagnon et al.
2000). Additionally, quantitative trait loci (QTLs) re-
lated to energy balance have been identified in human
(Norman et al. 1998) and mice (Moody et al. 1999).
Furthermore, statistical methods have been developed
for the analysis of epistatic effects between loci con-
trolling the trait (Cheverud and Routman 1995;
Mitchell et al. 1997; Wagner et al. 1998). For example,
evidence for increased susceptibility to diabetes caused
by interaction between genes has been demonstrated
in Mexican Americans (Cox et al. 1999).
In order to identify genetic components underly-
ing high body weight and obesity, we have explored
the genetically unique, extremely large and fat mouse
line DU6, which has twice the body weight and three
times the fat content of unselected control mice
(Bu¨nger et al. 1990). Muscle hypertrophy with in-
creased muscle diameter was found for high body
weight in line DU6 after 40 generations of selection
(Rehfeld and Bu¨nger 1990). Recently, we have detected
nine QTLs for body weight and eight QTLs for fat ac-
cumulation in a cross between line DU6 and the unse-
lected control, DUKs. These QTLs control about one-
third of the phenotypic variance of the traits within
the F2 population (Brockmann et al. 1998). The QTLs
have been designated as Bw4–Bw12 and Afw1–Afw8,
respectively (Mouse Genome Database [MGD]). Line
DU6 has been selected for 78 generations for high body
weight at the age of six weeks. The detected QTLs are
responsible for weight and obesity control at this age,
which corresponds to the end of the juvenile phase,
when animals are fertile. This age is interesting for hu-
man researchers because obesity or extreme size during
youth is critical for later onset of severe health impair-
ment, and it is of importance for animal breeders be-
cause it coincides with the period of slaughtering in
meat production.
The extreme phenotype of DU6 mice is accompa-
nied by hyperleptinemia, hyperinsulinemia, signifi-
cantly elevated insulin-like growth factor I (IGF-I) se-
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rum concentrations, and low growth hormone serum
levels (Timtchenko et al. 1999). Leptin, insulin, and
IGF-I are well known for their growth stimulating ef-
fects on metabolism and their influence upon differ-
entiation. Leptin is a peripheral signal modulating the
appetite and food consumption in interaction with the
central nerve system. Although leptin is essential for
avoidance of obesity, the increased leptin concentra-
tion in DU6 animals is in concordance with the obser-
vation of leptin-resistance in most obese human and
rodent models (Maffei et al. 1995). Candidate genes
responsible for the extremely high concentrations of
leptin, insulin and IGF-I in DU6 mice include Lep, Ins,
or Igf1 genes themselves, as well as their receptors and
binding proteins or other mediating factors. The two
mouse models of obesity, ob and db, are recessively
inherited mutations of the leptin encoding gene (Lep)
and its receptor (Lepr), respectively. The Lepr gene has
been identified as a candidate gene in our previous
study (Brockmann et al. 1998). At present, little is
known about additional genetic determination of the
serum concentrations of leptin, insulin, and IGF-I. Re-
cently, a locus contributing to plasma leptin concen-
trations but not obesity was identified on chromosome
4, near the leptin receptor gene in a cross between in-
bred mouse strains C57BL/6J and CAST/Ei (Mehrabian
et al. 1998). Evidence for linkage to insulin was found
for mouse chromosome 2 and the human homologous
chromosome 20 (Lembertas et al. 1997). Genetic loci
influencing insulin have been demonstrated in dia-
betic rats (Galli et al. 1999). To our knowledge, IGF-I
concentration has never been analyzed in QTL studies.
The control of IGF-I by Igf1 gene in our DU6 mice has
been shown by gene expression analyses (Brockmann
et al. 1996). To date, our analyses of body weight and
obesity have not found evidence of linkage to other
strong candidates such as Cpe, Lep, Tub, Ay, Ucp, and
Sim1. Thus, we assume that growth and obesity, in-
cluding serum proteins, are regulated by additional
genes that might interact with these genes to influence
body weight and obesity.
This study of an intercross between the high-body-
weight selected line DU6i and the commercial inbred
line DBA/2 is aimed at the discovery of QTLs underly-
ing body weight and obesity and genetic links between
loci controlling growth-related physiological param-
eters and QTLs responsible for body weight and devel-
opment of obesity. For the convenience of the genetic
research (fixation of microsatellite marker alleles), the
outbred selected line DU6 has been inbred for four gen-
erations to generate the partially inbred line DU6i,
which we used in this study.
We examined simultaneously the inheritance of
QTLs influencing body weight, fat accumulation, and
muscle development with the genetic control of serum
parameters leptin, insulin, and IGF-I. This experiment
permits the (1) analysis of the genetic correlation be-
tween the different growth measures and physiological
parameters, (2) the mapping of single quantitative trait
loci contributing to the complexity of body weight and
fat accumulation, as well as the pattern of genetic de-
terminants of the physiological action of leptin, insu-
lin, and IGF-I, and (3) the search for the genetic inter-
action between QTLs responsible for individual pheno-
type differences.
RESULTS
Line and Pedigree Characteristics
Data on the body composition characteristics and se-
rum concentrations of leptin, insulin, and IGF-I of
males from the lines DU6i and DBA/2 and the F2 are
presented in Table 1. Male mice of the selected line
DU6i show a mean body weight of 68.6 g at 42 d,
which is 274% greater than DBA/2 animals. The ex-
treme body weight coincides with high mean weights
Table 1. Characteristics of the Parental Mouse Lines
DU6i
Mean S.D.
(17 males)
DBA/2
Mean  S.D.
(20 males)
F2 Population
a
Mean  S.D.
(411 animals)
Body composition
Body weight (g) 68.6 3.96 18.3 1.6 31.05 3.83
Abdominal fat weight (mg) 1801 560 241 58 486 197
Abdominal fat percentage (%) 2.62 0.74 1.31 0.28 1.49 0.50
Muscle weight (mg) 617 42 240 28 339 52
Liver weight (mg) 4077 520 930 166 1745 266
Kidney weight (mg) 882 78 240 28 386 73
Spleen weight (mg) 275 67 78 13 156 51
Serum parameters
Leptin (ng/ml) 21.16 11.52 1.72 0.56 5.55 3.66
Insulin (pmol/L) 1651 982 <26 248 139
IGF-I (ng/ml) 750 151 238 39 616 121
aIndividual values were adjusted for the fixed effects of sex, number of repeated parity, subfamily, and pupsize.
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of abdominal fat tissue and muscle. Line DU6i differs
from the inbred line DBA/2 by 12.7 S.D. in body
weight, 2.8 S.D. in abdominal fat weight, and 9.0 S.D.
in muscle weight. Leptin, insulin, and IGF-I serum con-
centrations were elevated 12-fold, 63-fold, and 3.2-fold
in line DU6i as compared with line DBA/2, respec-
tively.
For linkage analysis, a pedigree of F2 intercross de-
sign by crossing the DU6i selected inbred line and the
DBA/2 inbred line has been generated (Table 2). Pear-
son’s correlation coefficients (r) between recorded
traits in mice of the F2 population are presented in
Table 3. Body weight, abdominal fat weight, and
muscle weight were highly correlated (r > 0.61). A high
correlation was also evident between abdominal fat
weight and the serum concentrations of leptin
(r = 0.69), as well as insulin (r = 0.49). The correlation
between muscle weight and leptin, and muscle weight
and insulin were r = 0.34 and r = 0.49, respectively. A
low correlation was found between IGF-I and body
composition (r < 0.31). Sex differences were found for
the correlation between serum proteins and the
weights of abdominal fat and muscle. For the serum
concentrations, we found a high correlation between
leptin and insulin (0.46), a low correlation between
leptin and IGF-I (0.17), and no correlation between
IGF-I and insulin.
Genome-Wide QTL Mapping
The F2 pedigree was genotyped for 93 loci. The markers
and their chromosomal locations are listed in Table 4.
The experiment–specific, genome-wide significance
levels were determined by permutation analysis. The
empirical F-value threshold was 9.86 for genome-wide
highly significant (P < 0.01) and 7.07 for genome-wide
significant (P < 0.05) linkage. The F-value thresholds
for the genome-wide suggestive levels of linkage,
equivalent to the F-values at the chromosome-wise 5%
levels, are shown in Table 5. They vary between chro-
mosomes depending on their length and the markers
they contain.
The estimates for the most likely positions and ef-
fects of QTLs suggestive at the chromosome-wise level
of significance detected in the pedigree are presented
for every chromosome in Table 5. Highly significant
QTLs (F > 9.86) were mapped for body weight on chro-
mosomes 1, 5, and 7; for abdominal fat weight and
liver and kidney weights on chromosome 7; for muscle
weight on chromosomes 7, 11, and 12; for spleen
weight on chromosome 10. Highly significant influ-
ence on the serum concentrations of IGF-I was found
for a QTL on chromosome 10. Positive estimates of
genetic effects indicate that alleles from the selected
line (DU6i) increase the trait. As expected, the great
majority of estimated genetic effects are in this direc-
tion. However, DU6i QTL alleles with decreasing ef-
fects compared to the DBA/2 allele were also detected.
Figure 1 displays the chromosomal positions of signifi-
cant QTLs relative to map positions of candidate genes
for the QTL effects.
The highest effect on body weight has been esti-
mated at a peak F-value of 25.91 at 28 cM from the
centromere on chromosome 7 (Bw14). The one-LOD
confidence interval of this QTL comprises a region of
10 cM with additional effect on fat accumulation
(F = 24.93 at 23 cM) and muscle development
(F = 19.49 at 29 cM), liver and kidney weight, and the
serum concentration of insulin (F = 6.2 at 32 cM). The
effect of the body weight QTL accounts for 12.3% of
the phenotypic variance within the F2 population. The
DU6i allele had an additive effect of 2.34 g on body
weight. The highly significant QTLs on chromosomes
1 (Bw5) and 5 (Bw13) account for 5.4 and 6%, respec-
tively, of the phenotypic F2 variance. The test for mul-
tiple QTLs influencing body weight was significant for
the highly significant effect of chromosome 11
(P < 0.01) and the significant QTL on chromosome 13
(P < 0.05). At least two QTLs reside on chromosome 11
at 14 cM (Bw16) and 55 cM (Bw4) and on chromosome
13 at 10 cM (Bw15) and 47 cM (Bw10). Most QTLs
influencing body weight were additive with an increas-
ing effect of the DU6i allele. The only exception was
Bw15 at chromosome 13 near the centromere, where
the DU6i allele caused a lower body weight of 1.23 g
compared to the DBA/2 allele. QTLs at the genome-
wide suggestive level were mapped to chromosomes 4
(Bw7 which has been confirmed in our previous study)
and 9. The net effect of all detected QTLs for body
weight explained 34.9 % of the phenotypic variance in
the F2 population.
Because total body weight is a reflection of fat ac-
cumulation and muscle development, these two traits
Table 2. F2 Pedigree Structure of the Initial Mating
between DBA/2 (Male) and DU6i (Female)
F2 Subfamily
Number of
offspring
(male; female)
Number of
offspring
with serum
parameters
(male; female)
1 (F15 F117) 32 (17; 15) 32 (17; 15)
2 (F16 F118) 34 (19; 15) 33 (19; 14)
3 (F17 F119) 26 (13; 13) 25 (13; 12)
4 (F18 F120) 45 (24; 21) 43 (23; 20)
5 (F19 F121) 25 (17; 8) 24 (17; 7)
6 (F110 F122) 28 (17; 11) 14 (8; 6)
7 (F111 F123) 20 (10; 10) 20 (10; 10)
8 (F112 F124) 51 (31; 20) 32 (18; 14)
9 (F113 F125) 38 (21; 17) 37 (20; 17)
10 (F114 F126) 50 (23; 27) 49 (23; 26)
11 (F115 F127) 37 (26; 11) 37 (26; 11)
12 (F116 F128) 25 (15; 10) 24 (14; 10)
Total 411 (233; 178) 370 (208; 162)
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were analyzed separately for their contribution to body
weight. The analyzed F2 population gave highly signifi-
cant evidence for QTLs responsible for muscle weight
on chromosomes 7, 11, and 12 and significant evi-
dence on chromosomes 1 and 13, in chromosomal re-
gions influencing body weight. Chromosome 7 was
harboring the QTL with the largest effect; this was at 23
cM and accounted for 9.6% of the phenotypic F2 vari-
ance (Mwq1). The analyses identified two QTLs respon-
sible for muscle weight (P < 0.05) on chromosome 11
at 10 cM (Mwq2) and 59 cM (Mwq3) and on chromo-
some 13 at10 cM and 43 cM (Mwq5). Corresponding to
the development of body weight, the additive genetic
effects of QTL alleles inherited from line DU6i in-
creased muscle development at all loci, except the
DU6i allele at 10 cM on chromosome 13, which re-
duced the muscle weight by 0.14 g. Together, muscle
weight QTLs accounted for 27.9% of the phenotypic
variance of muscle weight in the F2 population.
The inclusion of body weight as a covariate in the
analyses indicated that all of the QTLs influencing
body weight have an effect on fat and muscle weight
proportional to the overall phenotypic association be-
tween body weight, fatness, and muscle weight. Thus,
inclusion of body weight as a covariate in the analyses
removed all evidence of all QTLs identified for muscle
weight.
Estimated positions of QTLs responsible for ab-
dominal fat weight coincide with body-weight QTLs
on chromosomes 4, 5, 7, 11, 12, and 13. The largest
effect on abdominal fat weight was mapped at a peak
F-value of 24.9 on chromosome 7 (Afw9), and this ac-
counted for 12% of the phenotypic F2 variance. Al-
though three peaks were visible in the F-value curve
pertaining to chromosome 11, only two QTLs at 12
(Afw5) and 61 cM were found at P < 0.05 with influ-
ence on abdominal fat weight. Evidence for two fat
QTLs was found on chromosome 12 at 21 (Afw10) and
43 cM (P < 0.05). Additionally, QTLs for abdominal fat
weight were detected on chromosomes 3 (Afw1), 14 ,
17 (Afw7), and X (Afw11) these might be specific for fat
accumulation in the abdominal fat tissue, because
their effect on total body weight was not significant.
The identified fat QTLs differ in their effects. They were
mainly positive for the DU6i allele. However, the DU6i
allele caused less abdominal fat weight by an additive
genotype effect at chromosomes 3 (Afw1), 13 (Afw6),
and 17 (Afw7). Negative dominance components of
the QTL effect were present for DU6i alleles at Afw5 on
chromosome 11 and at Afw10 on chromosome 12.
Among the loci responsible for abdominal fat accumu-
lation, the QTL on the proximal part of chromosome
11 (Afw5) acts significantly differently (P < 0.05) in
males and females. It mainly influences fat accumula-
tion in females and shows negative heterosis
(d =117 mg, a = 74 mg), so that heterozygous ani-
mals showed a higher mean reduction of abdominal fat
weight than half the difference between the homozy-
gous genotypes. For males, an additive effect of 27 mg
was found for the DU6i allele. The net effect of all
Table 3. Pearson’s Correlation Coefficients between Measures of Body Composition and Serum Parameters
Sex BW AFW AFP MW LW KW SW Leptin Insulin IGF-I
BW male 1 0.75 0.57 0.84 0.88 0.77 0.16** 0.52 0.57 0.31
female 1
AFW male 0.76 1 0.95 0.61 0.57 0.50 (0.02) 0.69 0.49 0.28
female 0.74 1
AFP male 0.64 0.96 1 0.49 0.39 0.35 (0.08) 0.67 0.39 0.23
female 0.58 0.97 1
MW male 0.80 0.58 0.53 1 0.72 0.74 (0.00) 0.34 0.49 0.19
female 0.81 0.60 0.48 1
LW male 0.88 0.62 0.50 0.69 1 0.75 0.22 0.37 0.58 0.27
female 0.74 0.42 0.28 0.50 1
KW male 0.69 0.47 0.40 0.69 0.64 1 0.11* 0.26 0.51 0.24
female 0.81 0.55 0.42 0.70 0.72 1
SW male 0.18** (0.08) 0.15* (0.06) 0.26 (0.08) 1 (0.03) 0.11* (0.02)
female (0.03) (0.03) (0.04) (0.10) (0.08) (0.02) 1
Leptin male 0.53 0.69 0.69 0.28 0.39 0.18** (0.00) 1 0.46 0.17
female 0.49 0.67 0.66 0.36 0.27 0.33 (0.05) 1
Insulin male 0.47 0.51 0.50 0.36 0.46 0.32 (0.05) 0.53 1 (0.06)
female 0.37 0.33 0.28*** 0.34 0.28*** 0.38 (0.07) 0.28 1
IGF-I male 0.35 0.31 0.27 0.21** 0.33 0.28 (0.01) 0.17* (0.03) 1
female 0.26*** 0.21** 0.17* 0.15* 0.21** 0.24** (0.01) (0.12) (0.08) 1
BW, body weight; AFW, abdominal fat weight; AFP, abdominal fat percentage; MW, weight of quadriceps (musculus rectus femulus,
m. vastus intermedius, m. vastus lateralis, m. vastus medialis); LW, liver weight; KW, kidney weight; SW, spleen weight. Values above
the diagonal are for correlation over both sexes together; values below the diagonal are for males and females separately. Bold values
are significant at P < 0.0001. Asterisks mark different levels of significance: *P < 0.05, **P < 0.01, ***P < 0.001. Values in parentheses
are not significant.
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detected QTLs influencing abdominal fat weight ex-
plained 34.1% of the phenotypic variance in the F2
population.
Because the DU6i parent of the pedigree comes
from an outbred line following four generations of in-
breeding, five of the 93 markers (D2Mit6, D5Mit24,
D7Mit253, D7Mit259, D9Mit55) still were heterozygous
and, hence, a linked QTL might be heterozygous as
well. Therefore, we have analyzed the interactions be-
tween a QTL and subfamily for QTLs at the proximal
region of chromosome 2, the distal part of chromo-
somes 5, 7, and 9. There was significant evidence
(P < 0.001) that QTL genotypes differed between sub-
families for the QTL influencing abdominal fat weight
at 81 cM at the distal part of chromosome 5 (Afw3).
The inclusion of body weight as covariate in the analy-
ses removed QTLs responsible for abdominal fat weight
on chromosomes 5, 7, 11, 12, 13, and 14 but not those
on chromosomes 1, 4, 17 and X.
The most likely positions of QTLs influencing ab-
dominal fat percentage coincided with the chromo-
somal intervals identified for QTLs for abdominal fat
weight on chromosomes 3, 4, 7, 11, 12, 13, 17, and X.
No QTLs for abdominal fat percentage were found on
chromosomes 5 and 14 by which there were mapped
QTLs influencing abdominal fat weight. Correspond-
ing to abdominal fat weight, DU6i QTL alleles for fat
percentage on chromosomes 3, 13, and 17 and the fe-
male-specific effect on chromosome 11 at 12 cM act by
negative additive or dominant effect, while the other
DU6i QTL alleles had positive additive effects on ab-
dominal fat percentage.
Table 4. Markers Used for Linkage Analysis
Marker Location (cM) Marker Location (cM) Marker Location (cM)
D1Mit68 9.0 D7Mit21 0.5 D13Mit16 10.0
D1Mit236 25.7 D7Mit25 16.0 D13Mit139 32.0
D1Mit214 32.1 D7Mit26 24.0 D13Mit186 36.0
D1Mit46 43.1 D7Mit250 37.0 D13Mit130 61.0
D1Mit217 63.1 D7Mit253a 52.8 D13Mit78 75.0
D1Mit33 81.6 D7Mit259a 72.4
D1Mit16 87.2 D14Mit11 3.0
D1Mit36 92.8 D8Mit64 16.0 D14Mit183 19.5
D1Mit293 109.6 D8Mit249 37.0 D14Mit37 27.5
D8Mit245 72.0 D14Mit87 28.5
D2Mit6a 9.0 D14Mit162 44.0
D2Mit81b 13.0 D8Mit112c 21.0 D14Mit165 52.0
D2Mit92 40.0 D9Mit229 28.0
D2Mit447 60.0 D9Mit136 54.0 D15Mit12 6.4
D2Mit106 75.0 D9Mit55a 61.0 D15Mit46 26.4
D2Mit266 109.0 D15Mit37 48.5
D10Mit16 16.0 D15Mit193 57.9
D3Mit264 2.4 D10Mit186 40.0
D3Mit94 22.0 D10Mit73 62.0 D16Mit146 16.9
D3Mit25 29.5 D10Mit102 69.0 D16Mit5 38.0
D3Mit73 39.7
D3Mit42 58.8 D11Mit71 1.0 D17Mit113 6.5
D3Mit59 84.1 D11Mit19 14.0 D17Mit49 23.2
D11Mit310 25.0 D17Mit72 47.4
D4Mit94 10.6 D11Mit5 37.0 D17Mit123 56.7
D4Mit196 12.1 D11Mit30 39.8
D4Mit205 45.2 D11Mit120 47.5 D18Mit60 16.0
D4Mit37 56.5 D11Mit326 49.0 D18Mit7 50.0
D4Mit54 66.0 D11Mit67 58.0
D11Mit100 68.0 D19Mit30 20.0
D5Mit66 17.0 D11Mit104 79.0 D19Mit10 47.0
D5Mit58 41.0
D5Mit24a 60.0 D12Mit46 16.0 DXMit192 16.0
D5Mit95 68.0 D12Mit36 28.0 DXMit170 44.0
D5Mit221 81.0 D12Mit141 55.0 DXMit131 59.0
D6Mit139 2.5
D6Mit17 30.5
D6Mit149 46.3
D6Mit14 74.0
aHeterozygous DU6i parent.
bHeterozygous DBA/2 parent.
cThis marker has been reassigned to chromosome 9.
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QTLs for liver weight coincided with QTL posi-
tions for abdominal fat weight on chromosomes 5, 7,
and 12 and for body weight QTLs on chromosomes 1,
5, 7, and 9. Additionally, loci on chromosomes 4 (out-
side the most likely QTL interval for body weight and
fat), 15, and 18 were responsible for liver weight. The
genetic effects of the identified loci were predomi-
nantly additive. The joint effect of all QTLs accounted
for 31.3% of the F2 variance.
Significant QTLs affecting kidney weight were
mapped on chromosomes 2 and 7 at F-values of 7.59
and 14.5, respectively. Additional QTLs at the chromo-
some-wise suggestive level of significance were
mapped at the distal part of chromosomes 1, 14, and
18. The identified QTLs accounted for 17.3% of the
phenotypic F2 variation.
The genetic control of spleen weight differs from
the regulation of the other traits characterizing body
composition. A highly significant effect on spleen
weight was found for the QTL on chromosome 10,
with a peak F-value of 10.9 at 64 cM (Swq5). Genome-
wide significant loci with influence on spleen weight
were found on chromosomes 11 and 12. Chromosome-
wise suggestive QTLs were located on chromosomes 14
and 15. The DU6i alleles of the spleen QTLs on chro-
mosomes 10 and 12 reduced spleen weight relative to
the DBA/2 allele, while the other DU6i QTL alleles had
an increasing effect.
Significant evidence for the genetic regulation of
leptin concentration in serum, with a peak F-value of
7.58, was found on chromosome 14 at 28 cM (Lepq1).
The DU6i allele of this locus had an increasing additive
effect accounting for 4.4% of the phenotypic F2 vari-
ance of leptin, which was accompanied by increased
fat accumulation. Other genome-wide suggestive loci
changing the leptin concentration were identified on
chromosome 3 at 28 cM (F = 5.47), on the distal part of
chromosome 4 at 66 cM (F = 6.39), on chromosome 12
at 16 cM (F = 6.02), and on chromosome 19 at 47 cM
(F = 6.22). The loci on chromosomes 3 and 12 mapped
to regions that also effected fat accumulation. The lep-
tin QTL on chromosome 4 coincided with QTLs affect-
ing fat accumulation, body weight, and insulin. How-
ever, no influence of the leptin QTL on chromosome
19 was found on abdominal fat weight. Additionally,
QTLs with lesser effects on the serum concentration of
leptin were detected on chromosomes 1, 5, 11, and 13.
An increase of the serum leptin level by heterosis was
caused by the DU6i alleles on chromosome 1. The
chromosomal region on chromosome 13 that causes a
reduction of the serum leptin level by heterosis in
DU6i also has a reducing effect on fat accumulation.
The joint effect of all loci influencing leptin was 24.0%
of the phenotypic F2 variance.
For insulin concentration in serum, there was one
QTL on chromosome 4 at 61 cM (Insq1) that reached
the genome-wide significance threshold at F = 7.09.
This insulin locus coincided with a locus that effects
leptin concentration and Afw2 increasing fat accumu-
lation in DU6i. A genome-wide suggestive locus affect-
ing the serum insulin concentrations was detected on
chromosome 7, and a chromosome-wise suggestive lo-
cus was mapped to chromosome 15. The QTL at 32 cM
on chromosome 7 mapped together with QTLs influ-
encing fat accumulation (Afw9), body weight (Bw14),
muscle weight (Mwq1), and liver weight (Lwq6) in a 10
cM interval. The estimated effect of all QTLs in this
interval was additive, with increasing effects of the
DU6i alleles. The insulin QTL on chromosome 15 did
not have any apparent effect on other traits. The joint
effect of the detected loci affecting serum insulin con-
centration was 9.1% of the phenotypic variance within
the F2 population.
IGF-I was expected to influence body weight
mainly by promoting protein accretion and muscle de-
velopment. A major QTL (Igf1q1) responsible for dif-
ferences in the serum IGF-I concentration on chromo-
some 10 with a peak F-value of 29.7 at 38 cM from the
centromere, with a one LOD support interval of 13 cM
contributed most of the genetic variation detected. The
strong additive effect (0.056 logarithmic units, equiva-
lent to 81 ng/ml) accounted for 15.0% of the pheno-
typic variance of the trait in the F2 population. A sec-
ond highly significant QTL (Igf1q2) having additive in-
creasing effect of the DU6i allele was found on
chromosome 18 with a peak F-value of 9.51 at 39 cM.
The regions harboring the Igf1q1 and Igf1q2 QTLs did
not show any linkage to body, muscle, or fat weight.
Additionally, QTLs influencing the IGF-I concentra-
tion were found on chromosomes 2, 5, and 15. On
chromosome 5, the loci influencing the serum concen-
tration of IGF-I and leptin map within a 5-cM region.
The identified IGF-I QTLs accounted for 22.5% of the
phenotypic variance within the F2 population.
Interaction between QTLs
The effect of interaction between loci was tested for
body weight, abdominal fat weight, muscle weight,
and serum concentrations of leptin, insulin, and IGF-I.
The analysis of a specific trait (e.g., body weight) in-
cluded the test of interaction between markers linked
to QTLs influencing this specific trait (e.g., QTLs for
body weight) and, additionally, the test of interaction
between markers linked to QTLs responsible for differ-
ences of the other analyzed traits (e.g., QTLs for fat,
leptin, etc.). We chose this strategy because of the high
correlation between the body-composition traits and
the concentration of serum proteins and because of our
observation of colocated, but often small, subsignifi-
cant effects of QTLs identified for one trait on other
related traits.
Here we report results that proved significant in-
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teraction effects at P < 0.01. Five out of 40 (insulin) to
12 out of 264 (abdominal fat weight ) tests of epistasis
were significant at this level of significance for the dif-
ferent traits (Table 6). As we wanted to report all po-
tentially biologically important interactions, we chose
a relatively relaxed threshold, but in this study we fo-
cused our discussion on the most significant results.
The direct effects of markers and the effects of
locus*locus interaction are given for every trait in Table
6. Highly significant epistatic effects at P < 0.001 were
evident for the serum concentrations of leptin (C9-
61*C11-37), insulin (C4-56*C11-14) and IGF-I (C1-
43*C13-61, C7-37*C15-26, C14-44*C15-49).
Among the interactions affecting body weight, the
loci C18-50 and CX-16 interacted with two or more
different loci. For abdominal fat weight C14-44, C17-
47 (Afw7), C17-57 (Afw7), and C18-50 were found to
interact with two other loci, for muscle weight, C7-16
had interaction effects to two loci, for insulin, C4-56
(Insq1), and for IGF-I the loci C2-13 and C10-40
(Igf1q1), and C14-20 interacted with several other loci.
The interaction analysis provides evidence for co-
ordinated regulation of body and muscle weight by the
interaction of two pairs of loci (C2-9*C14-52 and C18-
50*CX-16) (Table 7). Additionally, the interaction be-
tween C18-50*CX-16 controls the serum concentration
of leptin. These interactions might contribute to the
high genetic correlation between body and muscle
weight.
The coincidence of interaction effects influencing
different traits by same marker loci is presented in
Table 7. The interaction effect of one marker locus on
different traits might indicate potential pleiotropic ef-
fects. The epistatic effect on the IGF-I serum concen-
tration that was found for the highly significant Igf1q1
QTL on chromosome 10 (C10-40) is of interest in this
respect. Although Igf1q1 had no direct effect on any
other traits and also interaction with the marker alleles
on chromosomes 11 (C11-1), 14 (C14-20), and 15 (C15-
6) had significant influence on IGF-I concentration
only, the loci interacting with Igf1q1 had potentially
pleiotropic effect on fat accumulation (C11-1), on
body weight, and leptin (C14-20), and on insulin (C15-
6) when interacting with other loci. A coordinate effect
on obesity was also found for genotypes of Igf1q2 at
C18-50, which affected body weight in a joint action
with C14-28 and CX-16 and affected abdominal fat
weight in interaction with chromosomes 2 and 16. Fur-
thermore, the leptin-influencing locus C19-47 had no
effect on obesity but influenced fat accumulation
when interacting with C11-48 (Bw4). Manifold inter-
action on growth and obesity was also found for chro-
mosome 14 harboring Lepq1. Many effects of interac-
tion between marker loci could be attributed to chro-
mosome 17 (preferentially at C17-57, which is close to
Afw7) and mainly affected obesity traits but did not
influence muscle weight). The markers covering chro-
mosome 11 interacted with several different loci on
other chromosomes to influence specifically either
protein, fat accumulation, or serum proteins.
Although the loci contributing to epistatic or
pleiotropic effects often individually explained little
trait variation, the coordinate effect of these loci on
two or even more traits when interacting with other
loci indicate a major role of the interacting chromo-
somal regions in the genetic determination of growth
and obesity. Table 8 gives an overview of total effects
on the phenotypic F2 population explained by direct
QTL effects, interaction effects, and QTL and interac-
tion effects together. The net effects of all interactions
found at the 0.01 significance level contributed 33%,
36%, and 21% to the F2 variance of body, fat, and
muscle weight, respectively. The interaction effects for
the serum concentration of proteins accounted for
30%, 20%, and 33% of the phenotypic F2 variance of
leptin, insulin, and IGF-I, respectively. The estimates
provide evidence that direct QTL and interaction ef-
fects together account for 64% and 63% of the pheno-
typic variance of body weight and abdominal fat
weight, respectively. QTL and interaction effects con-
tribute 32% of the phenotypic F2 variance of muscle
weight and 45% of the F2 variance of leptin, 21% of
insulin, and 42% of IGF-I.
DISCUSSION
We have analyzed a single pedigree from a cross of the
inbred high-growth selected mouse line DU6i with the
inbred line DBA/2. In this pedigree, we found high
correlations between the individual data on body com-
position and leptin and insulin serum concentrations.
The evidence of a considerable correlation between
leptin and muscle weight suggests that leptin may
have direct effects on fat and muscle tissues. Insulin
had similar correlations with both fat and muscle
weight. The observed interdependence between leptin
and insulin concentrations confirms findings in model
animal studies (Sivitz et al. 1997). The inhibition of
insulin by leptin in normal rodents (Poitout et al.
1998) seems to be distorted in DU6i mice. The corre-
lation between IGF-I and body composition was much
smaller than that for leptin and insulin.
Linkage analysis of the F2 pedigree indicated ten
chromosomal regions harboring genes with influence
on body weight, 12 regions affecting fat accumulation,
and seven regions responsible for muscle weight. Most
of the QTLs identified with effects significant at the
suggestive level on body weight, abdominal fat weight,
and liver weight were coincident to the QTL positions
mapped in our previous study (Brockmann et al. 1998).
Additionally, we have identified QTLs influencing
body weight on chromosomes 7 and 9, but no longer
see QTLs on chromosomes 15 and X. For abdominal fat
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Table 6. Account of Interaction to the Phenotypic F2 Variance for Every Trait
BW
Position
Position
effect (%)
C9–61
0.5
C11–48
6.1
C14–52
0.3
C15–58
0.9
C17–47
0.3
C18–50
0.3
CX–16
0.5
C1–82 2.1 4.8
C2–9 1.3 3.7
C2–13 0.9 3.9
C5–81 5.8 4.2
C11–14 3.6 4.6
C14–20 0.7 3.8
C14–28 1.0 4.1
C17–7 0.2 5.1
C18–50 0.5 4.5
AFW
Position
Position
effect (%)
C11–58
3.0
C12–16
2.9
C14–3
0.3
C15–58
0.2
C17–47
4.7
C17–57
4.5
C18–50
1.0
C19–47
0.6
CX–16
1.4
C2–13 1.1 3.8
C4–66 0.5 3.7
C5–81 3.5 5.2
C10–40 0.0 3.8
C11–1 1.0 4.4
C11–14 1.7 3.9
C11–48 1.8 3.6
C11–79 0.5 4.2
C13–61 0.0 4.4
C14–44 0.6 4.3 4.1
C16–17 0.2 4.0
MW
Position
Position
effect (%)
C7–16
9.4
C7–37
9.4
C14–28
0.2
C14–52
0.2
C16–17
0.2
C16–38
0.5
CX–16
0.8
C2–9 1.1 4.3
C2–75 0.0 4.2
C4–56 0.8 4.3
C7–16 9.4 4.0
C9–28 1.8 3.7
C11–37 4.9 3.8
C18–50 0.2 4.1
Leptin
Position
Position
effect (%)
C5–81
2.7
C11–37
0.9
C15–49
0.1
C16–38
0.3
C17–47
0.6
C19–47
3.2
CX–16
0.1
C1–82 2.0 4.9
C2–75 0.6 5.0
C9–28 0.3 4.3
C9–61 0.2 8.9
C14–20 2.1 4.6
C14–44 1.5 4.5
C18–50 1.3 4.4
Insulin
Position
Position
effect (%)
C4–66
3.3
C11–14
0.5
C15–6
1.5
C17–57
1.3
C18–50
0.2
C2–9 0.9 4.5
C4–56 2.8 4.9 6.7
C7–37 2.4 4.3
C14–28 0.9 4.6
IGF-I
Position
Positive
effect (%)
C2–60
1.6
C2–109
0.3
C11–1
0.2
C13–61
0.1
C14–20
0.2
C14–28
0.5
C15–6
0.6
C15–26
0.9
C15–49
0.8
C17–57
1.8
C1–9 2.7 4.8
C1–43 0.3 6.3
C2–13 0.3 4.5 3.9
C7–37 0.7 6.0
C10–40 14.3 4.6 5.4 4.2
C14–44 0.2 8.8
C14–52 0.9 4.6
The contingency tables for body weight (BW), abdominal fat weight (AFW), muscle weight (MW), and the serum levels of leptin,
insulin, and IGF-I present significant effects (P < 0.01) of the locus*locus interaction on every trait. The direct effect of a marker on a
trait is given below the marker in the heading and behind the marker in the left column. Significant direct effects at 0.01 are marked
bold. The direct marker effects on the F2 variance of a trait are given as reduction of the residual sum of squares with and without direct
marker effect in the model. The effect of the locus*locus interaction was estimated as the reduction of the residual sum of squares with
and without interaction effects in the model. Empty columns and rows were deleted from the contingency tables. Interaction effects
exceeding P < 0.001 significance are framed.
weight, additional QTLs were detected on chromosomes
7, 12, 14 and X, and two previously reported on chro-
mosomes 9 and 19 were not found. The X-chromosome-
linked obesity QTL coincided with recently reported
QTLs in KK (Taylor et al. 1999), AKR mouse lines (York et
al. 1997), and in divergent selected mice (Horvat et al.
2000). In general, loci responsible for growth also ef-
fected liver and kidney weight, while spleen weight
seemed to be regulated by completely different path-
ways. Differences in QTL detection between the two
crosses (DU6i x DBA/2 versus the previous cross DU6 x
DUKs) result primarily from the different genetic con-
trast but also from different random genotypic samples
and changes in environmental conditions.
Table 7. Traits Affected by Interaction between Loci that Directly Influence One of the Traits
Ig Ig In
,F
,L
F,
B
F B
,M
,In
Ig
**
F,
M
M
,F
,B
B B M
,F
L,
B
,F
B F*
*
F,
L
F,
L
Ig
**
In
,B
*
In
,B
*
B
**
Ig
,L
**
B
**
B
**
F F* Ig L F
Marker
position
QTLs
C
2–
60
C
2–
10
9
C
4–
66
C
5–
81
C
7–
16
C
7–
37
C
9–
61
C
11
–1
C
–1
1–
14
C
11
–3
7
C
11
–4
8
C
11
–5
8
C
12
–1
6
C
13
–6
1
C
14
–3
C
14
–2
0
C
14
–2
8
C
14
–5
2
C
15
–6
C
15
–2
6
C
15
–4
9
C
15
–5
8
C
16
–1
7
C
16
–3
8
C
17
–4
7
C
17
–5
7
C
18
–5
0
C
19
–4
7
C
X
–1
6
C1–9 B* Ig C1–9
C1–43 L,B,M Ig C1–43
C1–82 L L C1–82
C2–9 B**,F** B
M
In C2–9
C2–13 B** Ig B Ig F C2–13
C2–75 Ig M L C2–75
C4–56 B,In,F,L In M In C4–56
C4–66 B,In,F,L F C4–66
C5–81 F,B B F C5–81
C7–16 F M C7–16
C7–37 B,M,In In Ig C7–37
C9–28 B M L C9–28
C9–61 Ig** L C9–61
C10–40 Ig Ig Ig Ig F C10–40
C11–1 F,M F C11–1
C11–14 M,F,B F C11–14
C11–37 B M C11–37
C11–48 B F C11–48
C11–79 L**,Ig** F C11–79
C13–61 B F C13–61
C14–20 F,L B L C14–20
C14–28 F,L In B C14–28
C14–44 L**,F** Ig F F L C14–44
C14–52 Ig** Ig C14–52
C16–17 B**,In** F C16–17
C17–7 F** B C17–7
C18–50 Ig B
L
M
C18–7
C
2–
60
C
2–
10
9
C
4–
66
C
5–
81
C
7–
16
C
7–
37
C
9–
61
C
11
–1
C
11
–1
4
C
11
–3
7
C
11
–4
8
C
11
–5
8
C
12
–1
6
C
13
–6
1
C
14
–3
C
14
–2
0
C
14
–2
8
C
14
–5
2
C
15
–6
C
15
–2
6
C
15
–4
9
C
15
–5
8
C
16
–1
7
C
16
–3
8
C
17
–4
7
C
17
–5
7
C
18
–5
0
C
19
–4
7
C
X
–1
6
This is a condensed contingency table of 49 QTL-linked markers that were included in the interaction analysis. It shows affected traits
by pairwise locus interaction. Empty columns and rows resulting from markers that did not contribute any significant interaction effect
were omitted from the complete contingency table. Grey cells are on the diagonal of the full contingency table. Marker positions are
given as chromosome number and (cM) position (e.g., C1–9 for D1Mit68). Behind the marker positions, the traits are given that have
direct effect at the marker position (see Table 5). * indicates traits with nonsignificant effect in this study but which were significant
in the cross DU6xDUKs (Brockmann et al. 1998). ** indicates traits that suggest effects but did not reach the 0.1 significance threshold
in this study. All listed markers have at least interaction effect together with one other marker (i.e., QTL-linked markers were omitted
entirely if they were not involved in any interactions). Locus*locus interactions that influence two or more traits are marked bold.
B, body weight; F, abdominal fat weight; M, muscle weight; L, leptin; In, insulin; Ig, IGF-I.
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In this study, the biggest effects on body weight
and fatness were detected on chromosomes 7 and 11.
Although nonsuggestive linkage results have not been
shown here, the data on QTLs that were not seen in
one of the crosses have F-values for linkage, which sug-
gests an effect, as they were often just below the
threshold for suggestive linkage (data not shown). This
is one of the reasons that we have included all these
loci into the analysis of interaction between pairs of
markers linked with the analyzed traits. Additional
support for the existence of QTLs on growth and obe-
sity detected in this linkage analysis is provided by re-
sults from other QTL mapping studies for several dif-
ferent loci (West et al. 1994; Warden et al. 1995;
Cheverud et al. 1996; Keightley et al. 1996; Lembertas
et al. 1996, 1997; Taylor and Phillips 1996, 1997; Rance
et al. 1997; Kirkpatrick et al. 1998; Mehrabian et al.
1998; Moody et al. 1999; Morris et al. 1999; Horvat et
al. 2000).
The genetic effects of the identified QTLs are com-
plex. Most DU6i QTL alleles had additive increasing
effect. However, despite the high selection response of
DU6i, there were gene variants with smaller effects
than those of the inbred line DBA/2. In some cases,
heterosis was found for the action of the QTL alleles
with highest increase or reduction of the trait in het-
erozygous animals. The observed sex-dependent influ-
ence on abdominal fat weight of the QTLs on chromo-
some 11 is likely to be due to the different fat pads
measured in the two sexes, in males the testicular fat
and in females the perimetrial fat, which may be regu-
lated in a sex-specific manner. The finding of an influ-
ence of the subfamilies on the QTL on chromosome 5
affecting accumulation of abdominal fat suggests that
even after long-term selection and four generations of
inbreeding, not all alleles contributing to the heavy
body weight were fixed in line DU6i.
So far, muscle weight has not been included in any
linkage analyses. Our results indicate that the contri-
bution of all seven QTLs to the development of the
quadriceps is proportional to overall body-weight de-
velopment. The most obvious candidate genes within
the identified region are for chromosome 1, the myo-
statin gene (Mstn) and genes encoding IGF-binding
proteins 2 and 5 (Igfbp-2, Igfbp-5); for chromosome 7,
the insulin-like growth factor 1 receptor gene (Igf1r);
for chromosome 11, the genes encoding signal trans-
ducing factors 5 and 3 (Stat3, Stat5a,b), and growth
hormone (Gh); and for chromosome 12 the somato-
statin receptor 1 gene (Smstr1). No strong candidate
gene for muscle development is known for the two
regions on chromosome 13. Except the QTL on chro-
mosome 1, the loci influencing muscle weight on chro-
mosomes 7, 11, 12, and 13 coincide with loci having
effect on fat accumulation. This might be an indication
either on the pleiotropic effect of the underlying genes
or a hint on multiple genes having different effects in
the identified linkage groups.
Concerning the inheritance of high or low serum
concentrations of leptin, insulin, and IGF-I, we have
identified novel QTLs responsible for the extreme dif-
ference in all serum parameters between DU6i and
DBA/2 under nonfasting conditions. Although serum
concentrations have been mostly analyzed under fast-
ing conditions, the proteins are regulated by hunger, as
well as by repletion. For our selected line, DU6i, a
higher gross energetic efficiency (body energy gain/
gross energy intake) has been found in comparison
with controls, probably due to their increased capacity
for feed consumption resulting in a greater amount of
energy available for gain (Klein et al. 1999). Thus, the
physiological condition of nonfasting reflects the most
likely stage of rapidly-growing DU6i animals at ad li-
bitum food supply. As the serum concentration of the
measured proteins is influenced by the individual food
consumption at the time of slaughtering, we expected
and observed a high residual variance in our linkage
analyses, causing less power to detect the genetic de-
terminants for physiological differences. Thus, the
joint effects of the identified QTLs influencing serum
proteins were smaller compared to joint QTL effects
identified for body weight, fat accumulation, and
muscle weight. Nevertheless, the identified QTLs for
serum parameters and their interaction to other loci
contribute to search for nodal points of growth and
obesity regulation.
For the regulation of serum leptin concentration, a
Table 8. Joint Effect of the Identified QTLs and
Locus*Locus Interactions
Trait
Joint net
effect of
QTLsa (%)
Joint net
effect of
interactionb (%)
Joint net effect
of QTLs and
interaction
togetherb (%)
BW 34.9 32.9 64.4
AFW 34.1 35.5 62.8
AFP 26.2 n.d. n.d.
MW 27.9 20.7 31.8
LW 31.3 n.d. n.d.
KW 16.9 n.d. n.d.
SW 17.3 n.d. n.d.
Leptin 24.0 29.9 44.5
Insulin 9.1 20.3 21.2
IGF-I 22.5 32.8 41.6
The net effect is given as reduction of the residual sum of
squares with and without inclusion of all QTLs, all interactions,
or all QTLs and interactions together in the analysis.
aThe estimates for the joined net effect of all QTLs result from
multipoint linkage analysis using the most likely QTL position.
bThe estimates for the joined net effect of interaction and of
QTLs and interaction together result from the analysis using
the marker positions next to the most likely QTL positions
found via linkage analysis.
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significant influence of chromosome 14 most likely at
28.9 cM (Lepq1) was discovered. This leptin-regulating
locus has not been reported in either humans or in any
model animal. So far, no candidate gene is known for
the strong effect of this QTL, which might influence
the leptin concentration. The identified murine region
corresponds to human chromosome 14q11.2, of which
there has not been found human linkage to fat distri-
bution (Chagnon et al. 2000).
A locus with suggestive effect on leptin concentra-
tion was identified at 66 cM on chromosome 4. The
map position coincides with the recently identified
QTL in an intercross between C57BL/J6 and CAST/Ei
(Mehrabian et al. 1998). The most likely location of the
leptin QTL on chromosome 4 is distal to the Lepr gene.
Comparative sequencing of the Lepr gene in DU6i and
DBA/2 mice revealed an amino acid exchange in the
protein at amino acid position 359 (U. Reichart and G.
Brockmann, pers. comm.). This position is inside the
leptin-binding domain that has been localized to resi-
dues 323 to 640 (Fong et al. 1998). Thus, the identified
polymorphism might contribute to the identified QTL
effect of chromosome 4. Obviously, there is another
gene distal to Lepr responsible for the QTL effect on
serum leptin, fat accumulation, and body weight that
might interact with the Lepr locus. Our analysis indi-
cated a cosegregation of the locus influencing leptin
concentration with Insq1. This finding coincides with
the mapping of insulin-susceptible loci in NOD mice
(Idd9) (Rodrigues et al. 1994) and in NZO mice (Igel et
al. 1997). To the same chromosomal region, an effect
on heat loss was added (Moody et al. 1999).
Two loci on chromosomes 10 (Igf1q1) and 18
(Igf1q2) had major effect on IGF-I concentration. The
Igf1q1 QTL mapped directly at the Igf1 gene locus,
which most likely is the QTL underlying gene, as dif-
ferent IGF-I transcript amounts have been shown be-
tween selected DU6 and unselected mice (Timtchenko
et al. 1999). For Igf1q2 on chromosome 18 no candi-
date gene is known. The Igf1q1 and Igf1q2 loci itself did
not indicate effect on body, fat or muscle weight.
The analysis of interaction between loci contrib-
uted to the explanation of phenotypic variance in the
F2 population in a different manner: (1) The interac-
tion analysis showed loci that did not attribute to the
trait variance by itself but by interaction with other
loci. Examples for this kind of conclusion are loci re-
sponsible for leptin (Lepq1) or IGF-I (Igf1q1, Igf1q2),
which contributed to the phenotypic F2 variance of fat
and/or muscle weight only by interaction. (2) The in-
teraction analysis gave evidence for a pair of loci with
coordinate effect on correlated traits (e.g., the influ-
ence of C18-50*CX-16 on body and muscle weight and
leptin concentration). (3) The interaction analysis
proved loci potentially playing a central role in the
genetic regulation of complex phenotypes related to
growth and obesity by various types of regulation con-
tributed by a single marker locus. Two of these loci are
the distal part of chromosome 17 (C17-57) and the
middle part of chromosome 14 (C14-20) with influ-
ence on insulin and IGF-I, which might be an indica-
tion of major regulatory factors. (4) The interaction of
several different loci on one chromosome affecting di-
verse traits (fat, muscle, or serum proteins) helps dis-
tinguish multiple loci in the identified QTL linkage
group contributing by small effects to the variance,
rather than having one single gene responsible for the
estimated QTL effect. This situation might be assumed
for chromosome 11, for example. For chromosome 11,
two QTLs have been found for body, fat, and muscle
weight by test statistics. However, the genome-wide
interaction of different loci on chromosome 11 with
loci on other chromosomes allows us to expect at least
a third QTL near C11-37. The loci contributing to the
phenotypic variance by small effects only are difficult
to isolate, even by constructing congenic lines. The
identification of interacting chromosomal segments
may be used for the targeted construction of bicon-
genic lines, which combine the additive and dominant
effects of every locus and additionally the effect of in-
teraction.
The contribution of interaction effects to the phe-
notypic F2 variance was estimated at about one-third.
Together, the results of the QTL analysis and the locus*
locus interaction analysis contributed about two-thirds
of the phenotypic variance of body weight and ab-
dominal fat weight in the F2 population. The direct
QTL and interaction effects together considerably in-
crease the explained proportion of phenotypic F2 vari-
ance of muscle weight and the serum concentrations of
leptin, insulin, and IGF-I. The estimates might be bi-
ased due to the simplified model we used for the esti-
mation of interaction effect. Our tests are likely con-
servative in the estimation of effects contributing to
epistasis. This results mainly from recombination be-
tween the QTL and the marker position, which reduce
the estimates for additive and dominant genetic effects
and, thus, most likely, as well the genetic interaction.
Hence, for a more detailed analysis of the interaction
effects, the statistical tests of multipoint linkage analy-
sis have to be combined with interaction analysis of
most likely estimates of QTL locations as suggested by
Haley and Knott (1992) and Routman and Cheverud
(1997). Additionally, the evaluation of quantitative
changes of combined additive and dominant effects of
epistasis and pleiotropy is necessary, as compensatory
up- and down-regulation of correlated traits by gene
interaction is an important factor of genetic control of
body weight homeostasis (Gibson 1996). Nevertheless,
the identified QTL positions and interaction effects
from our cross may help to identify genes from the
relevant chromosomal region that underlay the com-
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plex net of gene actions responsible for growth and
obesity regulation.
METHODS
Mouse Lines
This study was carried out on the mouse line DU6i, which has
been inbred for four generations from the high-body-weight
selected line DU6 and the commercial inbred mouse line
DBA/2 (Harlan Nederland, Horst). The outbred line DU6 had
been selected for 78 generations for high body weight at the
age of 42 d (Bu¨nger et al. 1990). Line DU6 descends from
original crosses of four base (NMRI orig., Han: NMRI, CFW,
CF1) and four inbred (CBA/Bln, AB/Bln, C57BL/Bln, XVII/
Bln) populations at the Research Institute for the Biology of
Farm Animals, Dummerstorf, Germany (Schu¨ler 1985). Ani-
mals were fed ad libitum with a breeding diet containing 12.5
MJ/kg metabolic energy with an average content of 22.5%
crude protein, 5.0% crude fat, 4.5% crude fiber, 6.5% crude
ash, 13.5% water, 48.0% N-free extract, vitamins, trace ele-
ments, amino acids, and minerals (Altromin diet 1314, Ger-
many). Seventeen and 20 nonfasting males were analyzed for
DU6i and DBA/2, respectively, for the characterization of the
two mouse lines at 42 d.
Pedigree Design
QTL analysis was performed using a pedigree of F2 intercross
design. These were established by crossing one female of the
high-growth inbred line DU6i to one male of the contrast line
DBA/2. A large pedigree with a total of 411 F2 offspring was
generated by repeated mating of the parents and subse-
quently of repeated mating within subfamilies of 12 pairs of
F1 offspring. Mating was initially at the age of 10 wk and
repeated after 6 wk. The pedigree structure is shown in Ta-
ble 2.
Phenotypic Measures
The phenotypic data were recorded at 42 d of age, the age of
selection in all generations. The quantitative measurements
used in the QTL analysis were the weights of the body (BW),
abdominal fat (AFW), muscle (MW), liver (LW), kidney (KW),
and spleen (SW), as well as the serum concentrations of lep-
tin, insulin, and IGF-I. Nonfasting F2 animals were slaugh-
tered between 0900 and 1200. Animals were decapitated to
obtain the largest possible blood serum volumes for the analy-
sis of physiological parameters. The abdominal fat measured
in males was the testicular fat and in females the perimetrial
fat. The ratio of abdominal fat to body weight was defined as
abdominal fat percentage (AFP). The weight of the quadriceps
comprising musculus rectus femulus, musculus vastus inter-
medicus, musculus vastus lateralis, and musculus vastus me-
dialis was recorded as representative of muscle development
(MW).
Leptin was measured by the ‘Quantikine Murine’ en-
zyme-linked immunosorbert assay (ELISA) (R&D Systems,
Wiesbaden, Germany). The determination of insulin in
mouse sera was performed by an ultrasensitive rat insulin
ELISA (Diagnostic Research Group, Marburg, Germany),
which showed a 100% cross reactivity with mouse insulin.
IGF-I was determined by ELISA in serum after acid ethanol
extraction as described previously (Kratzsch et al. 1993).
Markers
Markers were chosen for their high variability between appro-
priate inbred lines from the mouse genome database (MGD).
Mouse MapPair primers were purchased from Research Genet-
ics. Over 630 microsatellite markers were tested for informa-
tive parental alleles, before the parents, and F2 were geno-
typed for 93 loci covering all chromosomes at an average
spacing of 14.1 cM. The marker map is shown in Table 4. DNA
preparation and genotyping were performed using standard
methods, as described by Das et al. (1996). All genotyping
results were scored twice and runs were repeated when there
were discrepancies.
Statistical Analysis
For linkage analysis, a pedigree specific marker map initially
was generated with the program CRIMAP (Lander and Green
1987). As the map was consistent with the published map—
marker D8Mit112 was reassigned to chromosome 9 (Jackson
et al. 1999)—we used the marker distances of the consensus
map of the mouse genome (Dietrich et al. 1996) for the map-
ping of QTLs. This allowed the direct incorporation of iden-
tified QTL positions to the consensus map in MGD. The dif-
ferences between the use of the consensus map and the pedi-
gree-specific map slightly changed F-values and estimates but
did not change the results in principle.
For the analysis of the pedigree, the influences of sex,
parity (five classes), subfamily (i.e., F2 animals from the same
pair of F1 parents: 12 classes), and pupsize (number of off-
spring per litter: five classes) initially were estimated for every
trait via variance analysis (SAS 1990). All factors were found to
be significant and, thus, were included as fixed effects in the
linkage analysis. The test for normality of the distribution
after adjusting the raw data for the fixed effects of sex, parity,
family, and pupsize (procedure capability, SAS) showed that
body weight, abdominal fat weight and percentage, muscle
weight, and the weights of the inner organs were normally
distributed. Leptin and IGF-I were normally distributed after
logarithmic transformation of the original serum concentra-
tion data. Therefore, logarithmic transformed data were used
throughout all analyses (correlation, linkage, interaction) of
leptin and IGF-I.
QTL analyses were performed by multiple regression (Ha-
ley et al. 1994). Initially, the standard interval mapping model
was used with a single QTL on the linkage group. Once a
single QTL on a chromosome was identified, the presence of
a second QTL was investigated by performing a grid search at
2 cM intervals. The two-QTLs model was accepted if there was
a significant improvement over the best possible one-QTL
model at the nominal P < 0.05 using a variance ratio (F) test
with 3 degrees of freedom (for the additional additive and
dominant effect and position estimated for the second QTL).
The obtained estimates were revised by fitting QTLs as back-
ground genetic effects on other linkage groups, as suggested
by Zeng (1993) and Jansen (1993). Background genetic effects
were included as cofactors for all loci showing effects at the
suggestive level of significance. During that procedure, a back-
ground effect was dropped from the analysis when analyzing
its own position. The sex chromosome was analyzed as a
pseudo-autosomal chromosome, as all markers were located
in that region. In additional analyses, body weight was intro-
duced as a covariate in the analysis of abdominal fat weight
and muscle weight to examine the dependence between these
traits. The joint effect of all identified QTLs for a trait (i.e.,
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variance explained of the F2) was estimated as reduction of
the residual mean square in the one QTL analysis fitting all
QTLs in comparison with no QTL fitted. Where a QTL was
identified, the interaction of the QTL effects with intrapedi-
gree subfamily and sex were tested and were accepted as sig-
nificant at the nominal level of P < 0.05.
The experiment-specific empirical threshold values of
the test statistics from the regression analysis were estimated
with the permutation test proposed by Churchill and Doerge
(1994). One thousand replicates were performed with a 1-cM
step size. Previous experience has shown that thresholds de-
rived by permutation analysis for different traits such as those
analyzed here are very similar. Therefore, we have used a com-
mon set of thresholds derived from permutation analysis of
body weight for all traits. Levels for genome-wide highly sig-
nificant ( = 0.01) and significant ( = 0.05) linkage were used
(Lander and Kruglyak 1995). The chromosome-wise 0.05 sig-
nificance levels were taken as genome-wide thresholds for
suggestive linkage. This is reasonable because using a 0.05
chromosomal threshold with each of 20 chromosomes (19
autosomes and the pseudo-autosomal region), we expect to
see one type-I error on average in the scan on all chromo-
somes. We used the one-LOD drop to provide an indicative
support interval for all genome-wide suggestive QTLs. Gene
symbols were assigned to QTLs exceeding the genome-wide
significant thresholds, to loci where two QTLs were found in
a linkage group (at P < 0.05) and both single QTLs were ge-
nome-wide suggestive (chromosome-wide significant at
P < 0.05) and to genome-wide suggestive QTLs that have been
confirmed from our previous study (Brockmann et al. 1998).
To examine the interaction between QTLs, we used the
general linear model of variance analysis (SAS). For a specific
QTL detected in the analyses with a single or two-linked QTLs,
the nearest marker was taken to analyze the interaction effect
between QTLs. The model of variance analysis included the
effects of sex, subfamily, parity, pupsize, the single effects of
the QTL identified for the specific trait at two selected loci,
and the interaction between these two specific loci. In the
interaction analysis, two degrees of freedom were used for
each marker fitted and four degrees of freedom for the inter-
action between two markers. Forty-nine out of 93 markers
were included in the analyses. Because independent multiple
tests were carried out, we used P < 0.001 as a stringent thresh-
old for our test statistics, and P < 0.01 as a relatively relaxed
threshold for the acceptance of interaction. We estimated the
effect of an interaction on the phenotypic F2 variance as re-
duction of residual sum of squares with and without inclusion
of the marker–marker interaction in the regression model.
The effects of single-marker loci on the trait were estimated
similarly. These may deviate from the estimated effect of a
linked QTL from the linkage analysis if the QTL position does
not exactly coincide with the marker position. For easier
tracking of interaction results, we used shortcuts for markers
that contained the chromosome number and the cM position
of the marker (e.g., C1-9 for D1Mit68 on chromosome 1 at 9
cM).
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